Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 135691, 15 pages
http://dx.doi.org/10.1155/2015/135691
Research Article

High Potency of a Novel Resveratrol Derivative, 3,3′,4,4′-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair

1Department of Pathophysiology, Poznan University of Medical Sciences, Rokietnicka 8 Street, 60-806 Poznan, Poland
2Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30 Street, 60-631 Poznan, Poland
3Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland
4Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteura 3, 02-093 Warsaw, Poland
5Division of Gynecological Surgery, Poznan University of Medical Sciences, Polna 33 Street, 60-535 Poznan, Poland

Received 8 April 2015; Revised 7 June 2015; Accepted 14 June 2015

Academic Editor: Gabriele Saretzki

Copyright © 2015 Justyna Mikuła-Pietrasik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Delmas, A. Lançon, D. Colin, B. Jannin, and N. Latruffe, “Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer,” Current Drug Targets, vol. 7, no. 4, pp. 423–442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. N.-H. Kang, K.-A. Hwang, H.-R. Lee, D.-W. Choi, and K.-C. Choi, “Resveratrol regulates the cell viability promoted by 17beta-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells,” Food and Chemical Toxicology, vol. 59, pp. 373–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Mikuła-Pietrasik, P. Sosińska, and K. Książek, “Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5β1 integrins and hyaluronic acid,” Gynecologic Oncology, vol. 134, no. 3, pp. 624–630, 2014. View at Publisher · View at Google Scholar
  4. C. Lin, D. R. Crawford, S. Lin et al., “Inducible COX-2-dependent apoptosis in human ovarian cancer cells,” Carcinogenesis, vol. 32, no. 1, pp. 19–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Cao, J. Fang, C. Xia, X. Shi, and B.-H. Jiang, “trans-3,4,5′-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells,” Clinical Cancer Research, vol. 10, no. 15, pp. 5253–5263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Vergara, P. Simeone, D. Toraldo et al., “Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells,” Molecular BioSystems, vol. 8, no. 4, pp. 1078–1087, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. U. Nessa, P. Beale, C. Chan, J. Q. Yu, and F. Huq, “Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells,” Anticancer Research, vol. 32, no. 1, pp. 53–59, 2012. View at Google Scholar · View at Scopus
  8. T. Walle, F. Hsieh, M. H. DeLegge, J. E. Oatis Jr., and U. K. Walle, “High absorption but very low bioavailability of oral resveratrol in humans,” Drug Metabolism and Disposition, vol. 32, no. 12, pp. 1377–1382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kucinska, H. Piotrowska, M. W. Luczak et al., “Effects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogs,” Chemico-Biological Interactions, vol. 209, no. 1, pp. 96–110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Murias, W. Jäger, N. Handler et al., “Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship,” Biochemical Pharmacology, vol. 69, no. 6, pp. 903–912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Saiko, Z. Horvath, M. Murias et al., “Antitumor effects of 3,3′,4,4′,5,5′-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells,” Nucleosides, Nucleotides and Nucleic Acids, vol. 25, no. 9–11, pp. 1013–1017, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Savio, T. Coppa, L. Bianchi et al., “The resveratrol analogue 4,4′-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol,” The International Journal of Biochemistry and Cell Biology, vol. 41, no. 12, pp. 2493–2502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Mikuła-Pietrasik, P. Sosińska, M. Murias et al., “Resveratrol derivative, 3,3′,4,4′-tetrahydroxy-trans-stilbene, retards senescence of mesothelial cells via hormetic-like prooxidative mechanism,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2014. View at Publisher · View at Google Scholar
  14. K. Ksia̧zek, J. Mikula-Pietrasik, K. Korybalska, G. Dworacki, A. Jörres, and J. Witowski, “Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion, the role of oxidative stress-induced fibronectin,” American Journal of Pathology, vol. 174, no. 4, pp. 1230–1240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Ksia̧zek, J. Mikuła-Pietrasik, R. Catar et al., “Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium,” International Journal of Cancer, vol. 127, no. 2, pp. 293–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Murias, N. Handler, T. Erker et al., “Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship,” Bioorganic and Medicinal Chemistry, vol. 12, no. 21, pp. 5571–5578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Domcke, R. Sinha, D. A. Levine, C. Sander, and N. Schultz, “Evaluating cell lines as tumour models by comparison of genomic profiles,” Nature Communications, vol. 4, article 2126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Pronk, P. Leguit, A. A. G. M. H. van Papendrecht, E. Hagelen, T. J. M. V. van Vroonhoven, and H. A. Verbrugh, “A cobblestone cell isolated from the human omentum: the mesothelial cell; isolation, identification, and growth characteristics,” In Vitro Cellular & Developmental Biology—Animal, vol. 29, no. 2, pp. 127–134, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. R. K. Gary and S. M. Kindell, “Quantitative assay of senescence-associated beta-galactosidase activity in mammalian cell extracts,” Analytical Biochemistry, vol. 343, no. 2, pp. 329–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. G. P. Dimri, X. Lee, G. Basile et al., “A biomarker that identifies senescent human cells in culture and in aging skin in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9363–9367, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Zhuang, J. T. Demirs, and I. E. Kochevar, “p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide,” Journal of Biological Chemistry, vol. 275, no. 34, pp. 25939–25948, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Debacq-Chainiaux, E. Boilan, J. Dedessus Le Moutier, G. Weemaels, and O. Toussaint, “p38(MAPK) in the senescence of human and murine fibroblasts,” in Protein Metabolism and Homeostasis in Aging, vol. 694 of Advances in Experimental Medicine and Biology, pp. 126–137, Springer, 2010. View at Publisher · View at Google Scholar
  23. H. Wahl, L. Tan, K. Griffith, M. Choi, and J. R. Liu, “Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells,” Gynecologic Oncology, vol. 105, no. 1, pp. 104–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G.-J. Fan, X.-D. Liu, Y.-P. Qian et al., “4,4′-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity,” Bioorganic and Medicinal Chemistry, vol. 17, no. 6, pp. 2360–2365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Trachootham, J. Alexandre, and P. Huang, “Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?” Nature Reviews Drug Discovery, vol. 8, no. 7, pp. 579–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Li, X. Lu, H. Xu et al., “Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on ‘oxidation therapy’,” Molecular Pharmaceutics, vol. 9, no. 2, pp. 222–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Li, W. K. K. Wu, Z. Zheng et al., “3,3′,4,5,5′-pentahydroxy-trans-stilbene, a resveratrol derivative, induces apoptosis in colorectal carcinoma cells via oxidative stress,” European Journal of Pharmacology, vol. 637, no. 1–3, pp. 55–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Murias, M. W. Luczak, A. Niepsuj et al., “Cytotoxic activity of 3,3′,4,4′,5,5′-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase,” Toxicology in Vitro, vol. 22, no. 5, pp. 1361–1370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Khan, H.-C. Chen, X.-X. Wan et al., “Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells,” Molecules and Cells, vol. 35, no. 3, pp. 219–225, 2013. View at Publisher · View at Google Scholar
  30. C. Mölzer, B. Pfleger, E. Putz et al., “In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells,” Experimental Cell Research, vol. 319, no. 4, pp. 536–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Boiteux and J. P. Radicella, “The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis,” Archives of Biochemistry and Biophysics, vol. 377, no. 1, pp. 1–8, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Ding, C. Han, D. Guo et al., “Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism,” Nutrition and Cancer, vol. 61, no. 3, pp. 348–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. V. N. Ayyagari and L. Brard, “Bithionol inhibits ovarian cancer cell growth In Vitro—studies on mechanism(s) of action,” BMC Cancer, vol. 14, no. 1, article 61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Marczak, B. Bukowska, and A. Rogalska, “WP 631 and Epo B synergize in SKOV-3 human ovarian cancer cells,” Environmental Toxicology and Pharmacology, vol. 37, no. 1, pp. 256–266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Piotrowska, K. Myszkowski, A. Ziółkowska et al., “Resveratrol analogue 3,4,4′,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells,” Toxicology and Applied Pharmacology, vol. 263, no. 1, pp. 53–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Chowdhury, B. Tharakan, and G. K. Bhat, “Caspases—an update,” Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, vol. 151, pp. 10–27, 2008. View at Google Scholar
  37. M. H. G. Raj, Z. Y. Abd Elmageed, J. Zhou et al., “Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells,” Gynecologic Oncology, vol. 110, no. 3, pp. 432–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Saiko, M. Pemberger, Z. Horvath et al., “Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity,” Oncology Reports, vol. 19, no. 6, pp. 1621–1626, 2008. View at Google Scholar · View at Scopus
  39. C. Maccario, M. Savio, D. Ferraro et al., “The resveratrol analog 4,4′-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells,” Carcinogenesis, vol. 33, no. 11, pp. 2172–2180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Luo, A. Yang, B. A. Schulte, M. J. Wargovich, and G. Y. Wang, “Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage,” PLoS ONE, vol. 8, no. 3, Article ID e60065, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. E. H. Heiss, Y. D. C. Schilder, and V. M. Dirsch, “Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells,” The Journal of Biological Chemistry, vol. 282, no. 37, pp. 26759–26766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Miku a-Pietrasik, P. Sosi ska, M. Murias et al., “Resveratrol derivative, 3,3′,4,4′-tetrahydroxy-trans-stilbene, retards senescence of mesothelial cells via hormetic-like prooxidative mechanism,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2014. View at Publisher · View at Google Scholar